DOSAGE FORMS FOR TYK2 INHIBITORS
Application
US20260083733A1
Kind: A1
Mar 26, 2026
Inventors
Sherif Ibrahim Farag Badawy, Jonathan R. Brown, Candice Y. Choi, Christoph Gesenberg, Vivienne Gray, John Wynne Jones, Umesh Kestur, Balvinder S. Vig, Xiaotian S. Yin, Christopher A. Zordan, Corey Bloom, lan Yates
Abstract
Stable and bioavailable formulations and dosage forms comprising a dispersion (e.g., spray-dried dispersion) of solid amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (Formula (I); BMS-986165) in a solid polymer matrix are provided for the treatment of auto-immune and auto-inflammatory diseases such as an inflammatory bowel disease (IBD) and psoriasis:
CPC Classifications
A61K 31/501
A61K 9/0053
A61K 9/2009
A61K 9/2013
A61K 9/2018
A61K 9/2054
A61K 9/284
A61K 45/06
Filing Date
2025-12-02
Application No.
19406921